Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) have been assigned an average recommendation of “Hold” from the four research firms that are currently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation. The average 12 month target price among analysts that have covered the stock in the last year is $9.38.
Several equities research analysts recently issued reports on MD shares. Mizuho cut their target price on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Jefferies Financial Group reduced their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Finally, Truist Financial reaffirmed a “hold” rating and set a $10.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, May 15th.
Get Our Latest Research Report on Pediatrix Medical Group
Institutional Inflows and Outflows
Pediatrix Medical Group Stock Performance
MD opened at $7.46 on Monday. The company has a market capitalization of $627.76 million, a price-to-earnings ratio of -8.78, a P/E/G ratio of 1.43 and a beta of 1.58. The business’s 50-day moving average price is $8.95 and its two-hundred day moving average price is $9.13. Pediatrix Medical Group has a 1 year low of $7.26 and a 1 year high of $15.02. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.72 and a quick ratio of 1.72.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.02. The company had revenue of $496.44 million for the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The firm’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the company earned $0.46 earnings per share. Equities analysts expect that Pediatrix Medical Group will post 1.12 EPS for the current fiscal year.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also
- Five stocks we like better than Pediatrix Medical Group
- How to Calculate Return on Investment (ROI)
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- How to Invest in Blue Chip Stocks
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- What is the FTSE 100 index?
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.